Abstract
IntroductionAutologous T-cells transduced to express a chimeric antigen receptor (CAR) directed against CD19 elicit high response rates in relapsed or refractory (r/r) B-cell non-Hodgkin lymphoma (B-NHL). However, r/r B-NHL remissions...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have